[Levismon, a new spasmonalgesic agent. Analysis of a clinical study].
D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D008875:Middle Aged; D009132:Muscles / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D010640:Phenothiazines / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use
D000700:Analgesics; D010640:Phenothiazines; D011720:Pyrazoles; D008614:Meperidine; D011398:Promethazine
Levismon, ein neues Spasmoanalgetikum- Analyse einer klinischen Prüfung.